PINOVA Capital invests in NEUROMEDEX
![](https://media.livingstonepartners.com/wp-content/uploads/2024/06/19080455/PDM-Brain2.jpg)
Together with Managing Director Markus Drewes, funds advised by PINOVA Capital GmbH (“PINOVA”) have agreed to acquire shares in the NEUROMEDEX group (“NEUROMEDEX”) from company founder Marco Geyer. The parties have agreed to keep the terms of this transaction confidential.
NEUROMEDEX is a leading provider of disposable products for neurosurgery and intensive care, based in Hamburg, Germany. NEUROMEDEX products allow neurosurgeons to monitor and regulate intracranial pressure in their patients’ brains with minimal infection risk.
The company and products set themselves apart by innovative solutions of the highest quality and usability, supporting doctors worldwide in saving lives day by day. In line with that, NEUROMEDEX products are highly valued by a broad and loyal customer base of hospitals, purchasing groups, and distributors domestically and internationally.
Marco Geyer, company founder and long-time Managing Director of NEUROMEDEX, emphasizes: “I am proud to have developed NEUROMEDEX into an innovative niche market leader with my employees and am now pleased to hand over the company to my long-time colleague and co-managing director Markus Drewes, as well as an experienced, value-oriented, partner like PINOVA that is well acquainted with the German Mittelstand. I would also like to thank our transaction advisor Livingstone Partners, particularly Jochen Hense, Matti Schroeder, and Lukas Windfuhr, for their trustworthy collaboration and advice, which enabled us to find the ideal partner.”
Jochen Hense of Livingstone Partners adds: “It is always a special feeling to support successful companies and entrepreneurs in finding the right partner for the future. We are pleased to have accompanied Mr. Geyer on this journey and congratulate him and PINOVA on the successful transaction.”
Markus Drewes, who has also invested in NEUROMEDEX as part of the transaction, comments: “We are very pleased to have found a partner in PINOVA who brings extensive experience in the strategic development and internationalization of mid-sized companies. Together with our team of long-term employees, who we are very proud of, and PINOVA we will push the go-to-market of new innovative products and the expansion of our international sales network.”
David Gilli, Director at PINOVA Capital, adds: “We are pleased to support Mr. Geyer in his company succession and are excited to lead this unique company into the next growth phase. As managing director and long-term senior employee, Markus Drewes, who has invested in the company alongside us, will significantly shape the course of success for the coming years. Together, we will further tap the growth potential of NEUROMEDEX within Europe and the rest of the world. We are very much looking forward to working together with him and the team.”
PINOVA was advised on the transaction by CMS (Legal), Singular (Market), AC Christes (Finance and Tax as well as Structuring), Regular Services (IP and Product), and Goodwin (Financing Documentation).
Marco Geyer was advised by Livingstone Partners (Sell-Side M&A) and BSP (Legal and Tax).
WE ARE passionate M&A advisors
We know our trade - and we don't just sell numbers. We develop a convincing story for your sale that combines all the key aspects into a coherent overall picture.WE ARE passionate M&A advisors
We know our trade - and we don't just sell numbers. We develop a convincing story for your sale that combines all the key aspects into a coherent overall picture.WE ARE passionate M&A advisors
We know our trade - and we don't just sell numbers. We develop a convincing story for your sale that combines all the key aspects into a coherent overall picture.WE ARE passionate M&A advisors
We know our trade - and we don't just sell numbers. We develop a convincing story for your sale that combines all the key aspects into a coherent overall picture.
- "I am proud to have developed NEUROMEDEX into an innovative niche market leader with my employees since it was founded and am delighted to now be able to hand the company over to my long-standing colleague and Co-Managing Director Markus Drewes and an experienced, value-oriented partner with an affinity for SMEs such as PINOVA. We would also like to take this opportunity to thank our transaction advisors Livingstone Partners, namely Jochen Hense, Matti Schroeder and Lukas Windfuhr, for their trusting cooperation and advice, which enabled us to find the ideal partner from our point of view."Marco Geyer, COMPANY FOUNDER AND MANAGING DIRECTOR, NEUROMEDEX
- Jochen Hense
Managing Partner Düsseldorf
"It is always a special feeling to support successful companies and entrepreneurs in finding the right partner for the future. We are therefore delighted to have been able to accompany Mr. Geyer on this journey and congratulate him and PINOVA on the successful transaction." - "We are delighted to have found a partner in PINOVA that has a wealth of experience in the strategic development and internationalization of medium-sized companies. Together with our team of long-standing employees, of whom we are very proud, and in combination with PINOVA’s experience, we will be implementing the marketing of new, innovative products and the expansion of our international sales network with determination."Markus Drewes, Managing Director, NEUROMEDEX
- "We are delighted to support Mr. Geyer with the company succession and to lead this unique company into the next phase of growth. With Markus Drewes, a managing director and long-standing senior employee who will play a decisive role in shaping the company’s success in the coming years, will be joining the company as part of the transaction. Together we will further develop the growth potential of NEUROMEDEX in the key sales regions of Europe and the rest of the world. We are very much looking forward to working together."David Gilli, Director, PINOVA Capital
Key Transaction Team
Additional Insights
- Livingstone Advises ACCESS PT on Partnership with Confluent HealthLivingstone’s Healthcare team has advised Access Physical Therapy & Wellness (“ACCESS PT” or the “Company”), a family-owned outpatient physical therapy platform operating 66 clinics across four states, on its new partnership with Confluent Health.
- Net32 has Received an Investment from Riverside PartnersLivingstone’s Healthcare and Business & Technology Services teams are delighted to announce that Net32, Inc. (“Net32” or the “Company”) has received an investment from Riverside Partners, LLC (“Riverside”). Deal terms were undisclosed. Net32 is the leading online marketplace for purchasing dental...
- NARCONOVA to implement future growth plans with OrtivityLivingstone has advised the anesthesiology practice group NARCONOVA on the sale of a majority stake to the orthopedic practice group Ortivity GmbH led by Apheon Capital.
- Physio CKI partners with Kapital 1852 to implement its growth plansLivingstone has advised the shareholders of Physio CKI Beteiligungs GmbH on the sale of a majority stake to Kapital 1852. The fast-growing Physio CKI Group brings Kapital 1852 on board, a growth partner set to support the further rollout of the established practice concept and regional expansion....